Skip to content
  • Twitter
  • Facebook
  • DMCA
  • Privacy Policy
  • Terms of Use
Market Newswire

Market Newswire

The Latest Press Releases

  • Business Wire
  • PR Newswire
  • Globe Newswire
  • OpenPR
  • IssueWire
  • US Newswire
  • SEC Filings
  • Toggle search form

Genetic Testing Market 2019 | Industry Trends, Technological Advancements, Market Dynamics, Business Overview, Competitive Landscape Analysis and Segmental Analysis By 2026 | Illumina, Inc., Thermo Fisher Scientific Inc.

Posted on November 30, 2021 By News Desk
Genetic Testing Market 2019 | Industry Trends, Technological Advancements, Market Dynamics, Business Overview, Competitive Landscape Analysis and Segmental Analysis By 2026 | Illumina, Inc., Thermo Fisher Scientific Inc. Genetic Testing Market The global genetic testing market was valued at USD 7,902 million in 2018 and is expected to grow at a CAGR of 11.8% during the forecast period. Genetic testing market is majorly driven by the increasing prevalence of genetic disorders,

Read more

OpenPR

Post navigation

Previous Post: Germicidal Ultraviolet Lamps Market Manufacturer, Analysis and Segment Information up to 2027|Cnlight, Philips, OSRAM
Next Post: RGB Laser Modules Market Growth Analysis, Trends, Developments and Forecast to 2027|Opt Lasers (Tomorrows System), Sumitomo Electric Industries

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021

Categories

  • Business Wire
  • Globe Newswire
  • IssueWire
  • OpenPR
  • PR Newswire
  • SEC Filings
  • Uncategorized
  • US Newswire

Recent Posts

  • 8-K Other Events – BUCKLE INC (0000885245) March 21
  • 8-K/A – FLOTEK INDUSTRIES INC/CN/ (0000928054) March 21
  • Investigation announced for Investors in Surmodics, Inc. (NASDAQ: SRDX) over potential Wrongdoing
  • Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update
  • Psychemedics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Declares Quarterly Cash Dividend

Copyright © 2023 Market Newswire.

Powered by PressBook WordPress theme

Go to mobile version